◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY
Home › All stocks › V › VLA

Valneva SE (VLA) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Biotechnology · DATA UPDATED 2026-08-16

Valneva SE (VLA) operates in the Biotechnology industry and is headquartered in Saint-Herblain, France with about 620 employees. Its market capitalization is roughly €613 million. In the fiscal year ended 2025-12-31, VLA reported €175M in revenue and (€115M) in net income.

Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.

Interactive charts & full statements →

VLA Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue€175M€170M€154M€361M—
Gross Profit€68M€71M€53M€37M—
Operating Income (EBIT)(€82M)(€78M)(€82M)(€113M)—
Net Income(€115M)(€12M)(€101M)(€143M)—

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

VLA Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Revenue€31M€48M€29M€48M€49M—
Gross Profit€5M€12M€6M€24M€26M—
Operating Income (EBIT)(€24M)(€28M)(€37M)(€11M)(€6M)—
Net Income(€32M)(€50M)(€44M)(€12M)(€9M)—

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

VLA Free Cash Flow History

Cash flow2025-12-312024-12-312023-12-312022-12-312021-12-31
Dividends Paid€0M€0M€0M€0M—

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

VLA Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Dividends Paid€0M€0M€0M€0M€0M—

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

VLA Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets€399M€500M€460M€621M—
Total Liabilities€293M€319M€332M€402M—

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive VLA viewer.

Other Companies in Biotechnology

← VKTXAll “V” companiesVLE →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.